Clin2
NCT06873165Possibly a fitRecruiting

Gut bacteria treatment for fatty liver disease

Metabolic Dysfunction-Associated Steatotic Liver Disease

Part of Digestive system, Hormones & metabolism clinical trials.

This study tests whether a specially designed gut bacteria treatment can help people with fatty liver disease and related health issues like high blood sugar, high cholesterol, or high blood pressure. It aims to see if the treatment is safe and improves liver health.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
40 people
Ages
18 years to 70 years
Study type
Interventional

Who can take part

  • You are between 20 and 70 years old.
  • You have fatty liver disease, confirmed by a FibroScan test, and at least one of these: a body mass index (BMI) of 23 or higher, a large waist size, high blood sugar or diabetes, high blood pressure, high triglycerides, or low 'good' cholesterol.
  • You have not taken probiotics, prebiotics, antibiotics, or certain anti-inflammatory drugs recently (within 14 to 30 days).
  • You are not pregnant, breastfeeding, or planning to travel outside the country for an extended period during the study.
  • You are willing to provide stool samples and follow all study procedures for about 6 months.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07083336Recruiting
Diet study for type 2 diabetes with fatty liver disease

This trial tests a specific medical nutrition therapy diet to see if it can reduce liver fat and improve blood sugar control in people with type 2 diabetes and nonalcoholic fatty liver disease. It may help you manage both conditions with a dietary approach.

Yichang, Hubei
NCT07400367Recruiting
Probiotics and lifestyle changes for fatty liver disease

This trial tests whether taking probiotics plus making lifestyle changes can improve fatty liver and metabolic health. You may qualify if you have liver fat and at least one sign of metabolic problems like high blood sugar or high blood pressure.

New Taipei City
NCT07025980Not yet recruiting· Phase 2
Probiotics for fatty liver disease

This study tests whether taking a probiotic supplement (a mix of helpful bacteria) can improve liver health in people with fatty liver disease linked to metabolic syndrome. It may help lower liver enzymes and reduce fat buildup in the liver.

Šibenik, Croatia
NCT06873412Not yet recruiting
Probiotic supplement for liver health and metabolism

This trial tests whether a probiotic supplement can improve liver health and metabolism in adults with early signs of fatty liver or related conditions. It may help reduce fat in the liver and improve blood sugar and blood pressure.

NCT07193927Recruiting· Phase 2
Testing a probiotic mix for fatty liver disease (MASLD)

This trial tests whether a probiotic mixture can improve liver health in people with moderate fatty liver disease (MASLD). It looks at how the probiotic affects liver fat, inflammation, and metabolism.

Girona, Girona
NCT06563921Not yet recruiting
Probiotic supplement for fatty liver disease

This study tests whether a probiotic supplement can improve liver health in people with fatty liver disease. It aims to see if probiotics reduce liver fat or inflammation, which could help manage the condition.

Hear when a new Metabolic Dysfunction-Associated Steatotic Liver Disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.